AbbVie Posts $16.99 Billion Q2 Revenue, Lifts Dividend to $1.73
Updated
Updated · Yahoo Finance · Aug 3
AbbVie Posts $16.99 Billion Q2 Revenue, Lifts Dividend to $1.73
3 articles · Updated · Yahoo Finance · Aug 3
Summary
AbbVie reported Q2 2026 revenue of $16.99 billion, up 10.2% from a year earlier, while adjusted EPS of $3.65 topped the $3.08 consensus.
Skyrizi drove much of the growth, contributing $5.51 billion in quarterly sales, a 24.4% increase that reinforced AbbVie's position as a major biopharma cash generator.
The company had already raised its quarterly dividend to $1.73 from $1.64 in late 2025, supported by a 4% free-cash-flow yield and a 32.85% operating margin.
At a 2.76% yield, a $15,000 stake would generate about $413 in annual income; shares are up 36.88% over the past year, tempering the yield despite the higher payout.